Mereo BioPharma (MREO) Tax Provisions (2023)
Mereo BioPharma (MREO) reported Tax Provisions of $532000.0 for Q4 2023.
Mereo BioPharma (MREO) Tax Provisions (2023) Analysis & Trends
Mereo BioPharma (MREO) has 1 years of Tax Provisions data on file, last reported at $532000.0 in Q4 2023.
- Tax Provisions for Q4 2023 came in at $532000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $532000.0 (changed N/A YoY), and the FY2023 annual result was $532000.0, up 174.09% from the prior year.
- Tax Provisions steadied at $532000.0 in Q4 2023 per MREO's latest filing.
- Over five years, Tax Provisions peaked at $532000.0 in Q4 2023 and troughed at $532000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 532,000.00 |